Why psychedelic mental health trials may be less reliable than they appear

Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called "blinding" because patients must be "blind" as to which they've received for the trial to work. Canadian researchers say this is a huge issue for studies of psychedelic therapies because it's fairly obvious to patients whether they've been given a psychedelic or a placebo.